Page last updated: 2024-08-23

diaziquone and Cancer of Prostate

diaziquone has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Damaschke, N; Guenther, C; Huang, W; Jarrard, D; McCormick, J; Truong, M; Wagner, J; Yang, B	1

Other Studies

1 other study(ies) available for diaziquone and Cancer of Prostate

Article	Year
Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence. PloS one, 2015, Volume: 10, Issue:4 Topics: Aged; Antineoplastic Agents; Aziridines; Benzoquinones; beta-Galactosidase; Biomarkers; Cellular Senescence; Epithelial Cells; Formaldehyde; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paraffin Embedding; Primary Cell Culture; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Survival Analysis; Tissue Fixation	2015

Article

Year

Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence.

PloS one, 2015, Volume: 10, Issue:4

Topics: Aged; Antineoplastic Agents; Aziridines; Benzoquinones; beta-Galactosidase; Biomarkers; Cellular Senescence; Epithelial Cells; Formaldehyde; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paraffin Embedding; Primary Cell Culture; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Survival Analysis; Tissue Fixation

2015